{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Future of discount safe harbor for prescription drugs remains uncertain",
"url": "https://www.lexblog.com/2021/12/23/future-of-discount-safe-harbor-for-prescription-drugs-remains-uncertain/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-8D0TYDR9",
"url": "https://www.lexblog.com/lib/8D0TYDR9/"
},
"datePublished": "2021-12-23T14:10:15-05:00",
"dateModified": "2022-07-22T13:39:21-04:00",
"author": {
"@type": "Person",
"name": "Ryan Pate"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Reed Smith LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Industry Washington Watch",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=21229",
"sourceStability": "may-move"
}